An error occurred retrieving content to display, please try again.
Page not found (404)
Sorry - the page you requested could not be found.
Please choose a page from the navigation or try a website search above to find the information you need.
-
Toolkit
1 School of Life Course Sciences, King’s College London, London, UK
2 Birmingham Clinical Trials Unit, University of Birmingham, Birmingham, UK
3 Action on Pre-eclampsia, Evesham, UK
4 National Perinatal Epidemiology Unit Clinical Trials Unit, Nuffield Department of Population Health, University of Oxford, Oxford, UK
5 Research Department of Primary Care and Population Health, University College London, London, UK
6 Guy’s and St Thomas’ NHS Foundation Trust, London, UK
7 Division of Cardiovascular Medicine, Radcliffe Department of Medicine, University of Oxford, Oxford, UK
8 Department of Obstetrics and Gynaecology, University of Cork, Cork, Ireland
9 School of Psychology and Life Sciences, Canterbury Christ Church University, Kent, UK
10 Population Health Institute, Newcastle University, Newcastle upon Tyne, UK
11 Fetal Medicine Unit, St George’s University Hospitals NHS Foundation Trust, London, UK
12 Frontier Science (Scotland) Ltd, Kincraig, UK
13 Nottingham Clinical Trials Unit, University of Nottingham, Nottingham, UK
14 Institute for Women’s Health, University College London, London, UK
* Corresponding author Email: lucy.chappell@kcl.ac.uk
Disclosure of interests of authors
Full disclosure of interests: Completed ICMJE forms for all authors, including all related interests, are available in the toolkit on the NIHR Journals Library report publication page at https://doi.org/10.3310/CWWH0622.
Primary conflicts of interest: Lucy C Chappell was chairperson of the National Institute for Health and Care Research (NIHR) Health Technology Assessment (HTA) Clinical Evaluation and Trials (CET) committee (2019–21) and is NIHR Chief Executive Officer (2021 to present). Pollyanna Hardy reports membership of the NIHR HTA Commissioning Board. Paul Leeson reports membership of the NIHR Invention for Innovation (i4i) Committee B and NIHR Fellowship Committee. Basky Thilaganathan reports honoraria for Key Opinion Leader (KOL) online lectures from Koninklijke Philips N.V. (Amsterdam, the Netherlands) and payments for sessional times. Edmund Juszczak reports membership of the NIHR HTA General Board (2013–16). Neil Marlow reports consulting fees from InfanDx AG (Cologne, Germany) and lecture fees from Chiesi UK (Manchester, UK). Andrew Shennan reports membership of the NIHR HTA Commissioning Board and is chairperson of the Action on Pre-eclampsia.
Funding: {{metadata.Funding}}
{{metadata.Journal}}, Volume: {{metadata.Volume}}, Issue: {{metadata.Issue}}, Published in {{metadata.PublicationDate | date:'MMMM yyyy'}}
https://doi.org/{{metadata.DOI}}
Citation: {{author}}{{ (($index < metadata.AuthorsArray.length-1) && ($index <=6)) ? ', ' : '' }} {{(metadata.AuthorsArray.length <= 6) ? '.' : '' }} {{(metadata.AuthorsArray.length > 6) ? 'et al.' : ''}} . {{metadata.JournalShortName}} {{metadata.PublicationDate | date:'yyyy'}}
Citation: {{metadata.Citation}}
This article has been published as part of the NIHR Journals Library new threaded publication model
Article Content
- Article Content
- Abstract
- Article Source
- Plain English Summary
- Plain Language Summary
- Scientific Summary
- More from this thread
The full text of this article is available as a PDF document from ...
The full text of this article is available as a PDF document from ...
Responses to this report
No responses have been published.